nodes	percent_of_prediction	percent_of_DWPC	metapath
Desvenlafaxine—CYP3A4—Imiquimod—skin cancer	0.197	0.292	CbGbCtD
Desvenlafaxine—CYP3A4—Temozolomide—skin cancer	0.197	0.292	CbGbCtD
Desvenlafaxine—CYP3A4—Vismodegib—skin cancer	0.137	0.202	CbGbCtD
Desvenlafaxine—CYP3A4—Vemurafenib—skin cancer	0.108	0.16	CbGbCtD
Desvenlafaxine—CYP3A4—Docetaxel—skin cancer	0.0371	0.0548	CbGbCtD
Desvenlafaxine—Skin disorder—Vismodegib—skin cancer	0.00233	0.00719	CcSEcCtD
Desvenlafaxine—Breast disorder—Imiquimod—skin cancer	0.00232	0.00717	CcSEcCtD
Desvenlafaxine—Stevens-Johnson syndrome—Vemurafenib—skin cancer	0.0023	0.00711	CcSEcCtD
Desvenlafaxine—Decreased appetite—Vismodegib—skin cancer	0.00208	0.00644	CcSEcCtD
Desvenlafaxine—Gastrointestinal disorder—Vismodegib—skin cancer	0.00207	0.00639	CcSEcCtD
Desvenlafaxine—Fatigue—Vismodegib—skin cancer	0.00206	0.00638	CcSEcCtD
Desvenlafaxine—Constipation—Vismodegib—skin cancer	0.00205	0.00633	CcSEcCtD
Desvenlafaxine—Connective tissue disorder—Vemurafenib—skin cancer	0.00205	0.00633	CcSEcCtD
Desvenlafaxine—Erectile dysfunction—Imiquimod—skin cancer	0.00204	0.00632	CcSEcCtD
Desvenlafaxine—Photosensitivity reaction—Imiquimod—skin cancer	0.00203	0.00626	CcSEcCtD
Desvenlafaxine—Interstitial lung disease—Docetaxel—skin cancer	0.00199	0.00616	CcSEcCtD
Desvenlafaxine—Erythema multiforme—Vemurafenib—skin cancer	0.00197	0.00609	CcSEcCtD
Desvenlafaxine—Stevens-Johnson syndrome—Imiquimod—skin cancer	0.00196	0.00606	CcSEcCtD
Desvenlafaxine—Acute coronary syndrome—Imiquimod—skin cancer	0.00195	0.00603	CcSEcCtD
Desvenlafaxine—Eye disorder—Vemurafenib—skin cancer	0.00195	0.00602	CcSEcCtD
Desvenlafaxine—Myocardial infarction—Imiquimod—skin cancer	0.00194	0.00599	CcSEcCtD
Desvenlafaxine—Cardiac disorder—Vemurafenib—skin cancer	0.00193	0.00597	CcSEcCtD
Desvenlafaxine—Angiopathy—Vemurafenib—skin cancer	0.00189	0.00584	CcSEcCtD
Desvenlafaxine—Mediastinal disorder—Vemurafenib—skin cancer	0.00188	0.0058	CcSEcCtD
Desvenlafaxine—Chills—Vemurafenib—skin cancer	0.00187	0.00578	CcSEcCtD
Desvenlafaxine—Alopecia—Vemurafenib—skin cancer	0.00184	0.00569	CcSEcCtD
Desvenlafaxine—Malnutrition—Vemurafenib—skin cancer	0.00181	0.0056	CcSEcCtD
Desvenlafaxine—Dysgeusia—Vemurafenib—skin cancer	0.00178	0.00549	CcSEcCtD
Desvenlafaxine—Urinary tract disorder—Imiquimod—skin cancer	0.00175	0.00542	CcSEcCtD
Desvenlafaxine—Myocardial ischaemia—Docetaxel—skin cancer	0.00175	0.00542	CcSEcCtD
Desvenlafaxine—Connective tissue disorder—Imiquimod—skin cancer	0.00175	0.00539	CcSEcCtD
Desvenlafaxine—Urethral disorder—Imiquimod—skin cancer	0.00174	0.00538	CcSEcCtD
Desvenlafaxine—Asthenia—Vismodegib—skin cancer	0.00172	0.00531	CcSEcCtD
Desvenlafaxine—Erythema multiforme—Imiquimod—skin cancer	0.00168	0.00519	CcSEcCtD
Desvenlafaxine—Eye disorder—Imiquimod—skin cancer	0.00166	0.00513	CcSEcCtD
Desvenlafaxine—Tinnitus—Imiquimod—skin cancer	0.00166	0.00512	CcSEcCtD
Desvenlafaxine—Hot flush—Temozolomide—skin cancer	0.00164	0.00508	CcSEcCtD
Desvenlafaxine—Diarrhoea—Vismodegib—skin cancer	0.00164	0.00507	CcSEcCtD
Desvenlafaxine—Menopausal symptoms—Temozolomide—skin cancer	0.00163	0.00504	CcSEcCtD
Desvenlafaxine—Angiopathy—Imiquimod—skin cancer	0.00161	0.00498	CcSEcCtD
Desvenlafaxine—Immune system disorder—Imiquimod—skin cancer	0.0016	0.00496	CcSEcCtD
Desvenlafaxine—Mediastinal disorder—Imiquimod—skin cancer	0.0016	0.00495	CcSEcCtD
Desvenlafaxine—Chills—Imiquimod—skin cancer	0.00159	0.00493	CcSEcCtD
Desvenlafaxine—Liver function test abnormal—Dactinomycin—skin cancer	0.00157	0.00485	CcSEcCtD
Desvenlafaxine—Alopecia—Imiquimod—skin cancer	0.00157	0.00485	CcSEcCtD
Desvenlafaxine—Bone disorder—Docetaxel—skin cancer	0.00156	0.00482	CcSEcCtD
Desvenlafaxine—Mental disorder—Imiquimod—skin cancer	0.00156	0.00481	CcSEcCtD
Desvenlafaxine—Malnutrition—Imiquimod—skin cancer	0.00155	0.00478	CcSEcCtD
Desvenlafaxine—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—skin cancer	0.00153	0.00474	CcSEcCtD
Desvenlafaxine—Toxic epidermal necrolysis—Dactinomycin—skin cancer	0.00153	0.00473	CcSEcCtD
Desvenlafaxine—Vomiting—Vismodegib—skin cancer	0.00152	0.00471	CcSEcCtD
Desvenlafaxine—Rash—Vismodegib—skin cancer	0.00151	0.00467	CcSEcCtD
Desvenlafaxine—Dermatitis—Vismodegib—skin cancer	0.00151	0.00466	CcSEcCtD
Desvenlafaxine—Nervous system disorder—Vemurafenib—skin cancer	0.00145	0.00449	CcSEcCtD
Desvenlafaxine—Skin disorder—Vemurafenib—skin cancer	0.00144	0.00444	CcSEcCtD
Desvenlafaxine—Weight decreased—Bleomycin—skin cancer	0.00143	0.00441	CcSEcCtD
Desvenlafaxine—Nausea—Vismodegib—skin cancer	0.00142	0.0044	CcSEcCtD
Desvenlafaxine—Gastrointestinal haemorrhage—Fluorouracil—skin cancer	0.00142	0.00438	CcSEcCtD
Desvenlafaxine—Angioedema—Imiquimod—skin cancer	0.00141	0.00437	CcSEcCtD
Desvenlafaxine—Blood pressure increased—Docetaxel—skin cancer	0.00141	0.00436	CcSEcCtD
Desvenlafaxine—Breast disorder—Temozolomide—skin cancer	0.00139	0.0043	CcSEcCtD
Desvenlafaxine—Syncope—Imiquimod—skin cancer	0.00139	0.00429	CcSEcCtD
Desvenlafaxine—Acute coronary syndrome—Bleomycin—skin cancer	0.00139	0.00428	CcSEcCtD
Desvenlafaxine—Toxic epidermal necrolysis—Temozolomide—skin cancer	0.00139	0.00428	CcSEcCtD
Desvenlafaxine—Myocardial infarction—Bleomycin—skin cancer	0.00138	0.00426	CcSEcCtD
Desvenlafaxine—Palpitations—Imiquimod—skin cancer	0.00137	0.00422	CcSEcCtD
Desvenlafaxine—Loss of consciousness—Imiquimod—skin cancer	0.00136	0.0042	CcSEcCtD
Desvenlafaxine—Irritability—Fluorouracil—skin cancer	0.00135	0.00418	CcSEcCtD
Desvenlafaxine—Convulsion—Imiquimod—skin cancer	0.00134	0.00414	CcSEcCtD
Desvenlafaxine—Hypertension—Imiquimod—skin cancer	0.00133	0.00413	CcSEcCtD
Desvenlafaxine—Anxiety—Imiquimod—skin cancer	0.00131	0.00405	CcSEcCtD
Desvenlafaxine—Unspecified disorder of skin and subcutaneous tissue—Imiquimod—skin cancer	0.00131	0.00404	CcSEcCtD
Desvenlafaxine—Stevens-Johnson syndrome—Dactinomycin—skin cancer	0.0013	0.00402	CcSEcCtD
Desvenlafaxine—Dry mouth—Imiquimod—skin cancer	0.00129	0.00398	CcSEcCtD
Desvenlafaxine—Decreased appetite—Vemurafenib—skin cancer	0.00129	0.00398	CcSEcCtD
Desvenlafaxine—Gastrointestinal disorder—Vemurafenib—skin cancer	0.00128	0.00395	CcSEcCtD
Desvenlafaxine—Fatigue—Vemurafenib—skin cancer	0.00128	0.00394	CcSEcCtD
Desvenlafaxine—Constipation—Vemurafenib—skin cancer	0.00127	0.00391	CcSEcCtD
Desvenlafaxine—Shock—Imiquimod—skin cancer	0.00124	0.00384	CcSEcCtD
Desvenlafaxine—Nervous system disorder—Imiquimod—skin cancer	0.00124	0.00382	CcSEcCtD
Desvenlafaxine—Tachycardia—Imiquimod—skin cancer	0.00123	0.00381	CcSEcCtD
Desvenlafaxine—Skin disorder—Imiquimod—skin cancer	0.00123	0.00379	CcSEcCtD
Desvenlafaxine—Erectile dysfunction—Temozolomide—skin cancer	0.00122	0.00379	CcSEcCtD
Desvenlafaxine—Hyperhidrosis—Imiquimod—skin cancer	0.00122	0.00377	CcSEcCtD
Desvenlafaxine—Photosensitivity reaction—Temozolomide—skin cancer	0.00121	0.00375	CcSEcCtD
Desvenlafaxine—Weight increased—Temozolomide—skin cancer	0.00121	0.00374	CcSEcCtD
Desvenlafaxine—Weight decreased—Temozolomide—skin cancer	0.0012	0.00372	CcSEcCtD
Desvenlafaxine—Stevens-Johnson syndrome—Temozolomide—skin cancer	0.00118	0.00363	CcSEcCtD
Desvenlafaxine—Insomnia—Imiquimod—skin cancer	0.00114	0.00353	CcSEcCtD
Desvenlafaxine—Paraesthesia—Imiquimod—skin cancer	0.00113	0.0035	CcSEcCtD
Desvenlafaxine—Chills—Bleomycin—skin cancer	0.00113	0.0035	CcSEcCtD
Desvenlafaxine—Somnolence—Imiquimod—skin cancer	0.00112	0.00347	CcSEcCtD
Desvenlafaxine—Photosensitivity reaction—Fluorouracil—skin cancer	0.00112	0.00346	CcSEcCtD
Desvenlafaxine—Alopecia—Bleomycin—skin cancer	0.00111	0.00345	CcSEcCtD
Desvenlafaxine—Erythema multiforme—Dactinomycin—skin cancer	0.00111	0.00344	CcSEcCtD
Desvenlafaxine—Decreased appetite—Imiquimod—skin cancer	0.0011	0.00339	CcSEcCtD
Desvenlafaxine—Hot flush—Docetaxel—skin cancer	0.00109	0.00338	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Vemurafenib—skin cancer	0.00109	0.00337	CcSEcCtD
Desvenlafaxine—Gastrointestinal disorder—Imiquimod—skin cancer	0.00109	0.00337	CcSEcCtD
Desvenlafaxine—Fatigue—Imiquimod—skin cancer	0.00109	0.00336	CcSEcCtD
Desvenlafaxine—Menopausal symptoms—Docetaxel—skin cancer	0.00108	0.00335	CcSEcCtD
Desvenlafaxine—Acute coronary syndrome—Fluorouracil—skin cancer	0.00108	0.00333	CcSEcCtD
Desvenlafaxine—Myocardial infarction—Fluorouracil—skin cancer	0.00107	0.00331	CcSEcCtD
Desvenlafaxine—Asthenia—Vemurafenib—skin cancer	0.00106	0.00328	CcSEcCtD
Desvenlafaxine—Hallucination—Temozolomide—skin cancer	0.00106	0.00327	CcSEcCtD
Desvenlafaxine—Chills—Dactinomycin—skin cancer	0.00106	0.00326	CcSEcCtD
Desvenlafaxine—Urinary tract disorder—Temozolomide—skin cancer	0.00105	0.00325	CcSEcCtD
Desvenlafaxine—Connective tissue disorder—Temozolomide—skin cancer	0.00105	0.00323	CcSEcCtD
Desvenlafaxine—Urethral disorder—Temozolomide—skin cancer	0.00104	0.00322	CcSEcCtD
Desvenlafaxine—Alopecia—Dactinomycin—skin cancer	0.00104	0.00321	CcSEcCtD
Desvenlafaxine—Epistaxis—Fluorouracil—skin cancer	0.00103	0.00318	CcSEcCtD
Desvenlafaxine—Hyponatraemia—Docetaxel—skin cancer	0.00103	0.00318	CcSEcCtD
Desvenlafaxine—Gastrointestinal haemorrhage—Docetaxel—skin cancer	0.00102	0.00316	CcSEcCtD
Desvenlafaxine—Diarrhoea—Vemurafenib—skin cancer	0.00101	0.00313	CcSEcCtD
Desvenlafaxine—Erythema multiforme—Temozolomide—skin cancer	0.00101	0.00311	CcSEcCtD
Desvenlafaxine—Eye disorder—Temozolomide—skin cancer	0.000995	0.00307	CcSEcCtD
Desvenlafaxine—Tinnitus—Temozolomide—skin cancer	0.000992	0.00307	CcSEcCtD
Desvenlafaxine—Cardiac disorder—Temozolomide—skin cancer	0.000988	0.00305	CcSEcCtD
Desvenlafaxine—Dizziness—Vemurafenib—skin cancer	0.000978	0.00302	CcSEcCtD
Desvenlafaxine—Angiopathy—Temozolomide—skin cancer	0.000966	0.00298	CcSEcCtD
Desvenlafaxine—Immune system disorder—Temozolomide—skin cancer	0.000961	0.00297	CcSEcCtD
Desvenlafaxine—Mediastinal disorder—Temozolomide—skin cancer	0.000959	0.00297	CcSEcCtD
Desvenlafaxine—Chills—Temozolomide—skin cancer	0.000955	0.00295	CcSEcCtD
Desvenlafaxine—Liver function test abnormal—Docetaxel—skin cancer	0.000945	0.00292	CcSEcCtD
Desvenlafaxine—Vomiting—Vemurafenib—skin cancer	0.000941	0.00291	CcSEcCtD
Desvenlafaxine—Alopecia—Temozolomide—skin cancer	0.00094	0.00291	CcSEcCtD
Desvenlafaxine—Orthostatic hypotension—Docetaxel—skin cancer	0.000934	0.00289	CcSEcCtD
Desvenlafaxine—Rash—Vemurafenib—skin cancer	0.000933	0.00288	CcSEcCtD
Desvenlafaxine—Mental disorder—Temozolomide—skin cancer	0.000932	0.00288	CcSEcCtD
Desvenlafaxine—Dermatitis—Vemurafenib—skin cancer	0.000932	0.00288	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Imiquimod—skin cancer	0.00093	0.00287	CcSEcCtD
Desvenlafaxine—Headache—Vemurafenib—skin cancer	0.000927	0.00287	CcSEcCtD
Desvenlafaxine—Malnutrition—Temozolomide—skin cancer	0.000926	0.00286	CcSEcCtD
Desvenlafaxine—Breast disorder—Docetaxel—skin cancer	0.000925	0.00286	CcSEcCtD
Desvenlafaxine—Toxic epidermal necrolysis—Docetaxel—skin cancer	0.000921	0.00285	CcSEcCtD
Desvenlafaxine—Dysgeusia—Temozolomide—skin cancer	0.000907	0.0028	CcSEcCtD
Desvenlafaxine—Asthenia—Imiquimod—skin cancer	0.000905	0.0028	CcSEcCtD
Desvenlafaxine—Nausea—Vemurafenib—skin cancer	0.000879	0.00272	CcSEcCtD
Desvenlafaxine—Vision blurred—Temozolomide—skin cancer	0.000873	0.0027	CcSEcCtD
Desvenlafaxine—Tremor—Temozolomide—skin cancer	0.000868	0.00268	CcSEcCtD
Desvenlafaxine—Alopecia—Fluorouracil—skin cancer	0.000867	0.00268	CcSEcCtD
Desvenlafaxine—Diarrhoea—Imiquimod—skin cancer	0.000863	0.00267	CcSEcCtD
Desvenlafaxine—Angioedema—Temozolomide—skin cancer	0.000847	0.00262	CcSEcCtD
Desvenlafaxine—Dizziness—Imiquimod—skin cancer	0.000834	0.00258	CcSEcCtD
Desvenlafaxine—Vertigo—Temozolomide—skin cancer	0.000832	0.00257	CcSEcCtD
Desvenlafaxine—Palpitations—Temozolomide—skin cancer	0.000819	0.00253	CcSEcCtD
Desvenlafaxine—Paraesthesia—Bleomycin—skin cancer	0.000805	0.00249	CcSEcCtD
Desvenlafaxine—Weight increased—Docetaxel—skin cancer	0.000805	0.00249	CcSEcCtD
Desvenlafaxine—Vision blurred—Fluorouracil—skin cancer	0.000804	0.00249	CcSEcCtD
Desvenlafaxine—Convulsion—Temozolomide—skin cancer	0.000803	0.00248	CcSEcCtD
Desvenlafaxine—Vomiting—Imiquimod—skin cancer	0.000802	0.00248	CcSEcCtD
Desvenlafaxine—Weight decreased—Docetaxel—skin cancer	0.0008	0.00247	CcSEcCtD
Desvenlafaxine—Hypertension—Temozolomide—skin cancer	0.0008	0.00247	CcSEcCtD
Desvenlafaxine—Rash—Imiquimod—skin cancer	0.000796	0.00246	CcSEcCtD
Desvenlafaxine—Dermatitis—Imiquimod—skin cancer	0.000795	0.00246	CcSEcCtD
Desvenlafaxine—Headache—Imiquimod—skin cancer	0.00079	0.00244	CcSEcCtD
Desvenlafaxine—Anxiety—Temozolomide—skin cancer	0.000786	0.00243	CcSEcCtD
Desvenlafaxine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.000783	0.00242	CcSEcCtD
Desvenlafaxine—Stevens-Johnson syndrome—Docetaxel—skin cancer	0.000782	0.00242	CcSEcCtD
Desvenlafaxine—Decreased appetite—Bleomycin—skin cancer	0.000779	0.00241	CcSEcCtD
Desvenlafaxine—Acute coronary syndrome—Docetaxel—skin cancer	0.000777	0.0024	CcSEcCtD
Desvenlafaxine—Myocardial infarction—Docetaxel—skin cancer	0.000773	0.00239	CcSEcCtD
Desvenlafaxine—Dry mouth—Temozolomide—skin cancer	0.000771	0.00238	CcSEcCtD
Desvenlafaxine—Nausea—Imiquimod—skin cancer	0.000749	0.00232	CcSEcCtD
Desvenlafaxine—Epistaxis—Docetaxel—skin cancer	0.000744	0.0023	CcSEcCtD
Desvenlafaxine—Nervous system disorder—Temozolomide—skin cancer	0.000742	0.00229	CcSEcCtD
Desvenlafaxine—Convulsion—Fluorouracil—skin cancer	0.00074	0.00229	CcSEcCtD
Desvenlafaxine—Skin disorder—Temozolomide—skin cancer	0.000734	0.00227	CcSEcCtD
Desvenlafaxine—Hyperhidrosis—Temozolomide—skin cancer	0.000731	0.00226	CcSEcCtD
Desvenlafaxine—Decreased appetite—Dactinomycin—skin cancer	0.000727	0.00225	CcSEcCtD
Desvenlafaxine—Fatigue—Dactinomycin—skin cancer	0.000721	0.00223	CcSEcCtD
Desvenlafaxine—Urinary tract disorder—Docetaxel—skin cancer	0.000699	0.00216	CcSEcCtD
Desvenlafaxine—Connective tissue disorder—Docetaxel—skin cancer	0.000696	0.00215	CcSEcCtD
Desvenlafaxine—Urethral disorder—Docetaxel—skin cancer	0.000694	0.00214	CcSEcCtD
Desvenlafaxine—Insomnia—Temozolomide—skin cancer	0.000684	0.00211	CcSEcCtD
Desvenlafaxine—Nervous system disorder—Fluorouracil—skin cancer	0.000683	0.00211	CcSEcCtD
Desvenlafaxine—Tachycardia—Fluorouracil—skin cancer	0.00068	0.0021	CcSEcCtD
Desvenlafaxine—Paraesthesia—Temozolomide—skin cancer	0.000679	0.0021	CcSEcCtD
Desvenlafaxine—Somnolence—Temozolomide—skin cancer	0.000672	0.00208	CcSEcCtD
Desvenlafaxine—Erythema multiforme—Docetaxel—skin cancer	0.000669	0.00207	CcSEcCtD
Desvenlafaxine—Eye disorder—Docetaxel—skin cancer	0.000661	0.00204	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Bleomycin—skin cancer	0.00066	0.00204	CcSEcCtD
Desvenlafaxine—Decreased appetite—Temozolomide—skin cancer	0.000657	0.00203	CcSEcCtD
Desvenlafaxine—Cardiac disorder—Docetaxel—skin cancer	0.000657	0.00203	CcSEcCtD
Desvenlafaxine—Gastrointestinal disorder—Temozolomide—skin cancer	0.000653	0.00202	CcSEcCtD
Desvenlafaxine—Fatigue—Temozolomide—skin cancer	0.000652	0.00202	CcSEcCtD
Desvenlafaxine—Constipation—Temozolomide—skin cancer	0.000647	0.002	CcSEcCtD
Desvenlafaxine—Asthenia—Bleomycin—skin cancer	0.000643	0.00199	CcSEcCtD
Desvenlafaxine—Angiopathy—Docetaxel—skin cancer	0.000642	0.00198	CcSEcCtD
Desvenlafaxine—Immune system disorder—Docetaxel—skin cancer	0.000639	0.00198	CcSEcCtD
Desvenlafaxine—Mediastinal disorder—Docetaxel—skin cancer	0.000638	0.00197	CcSEcCtD
Desvenlafaxine—Chills—Docetaxel—skin cancer	0.000635	0.00196	CcSEcCtD
Desvenlafaxine—Insomnia—Fluorouracil—skin cancer	0.00063	0.00195	CcSEcCtD
Desvenlafaxine—Paraesthesia—Fluorouracil—skin cancer	0.000626	0.00193	CcSEcCtD
Desvenlafaxine—Alopecia—Docetaxel—skin cancer	0.000625	0.00193	CcSEcCtD
Desvenlafaxine—Mental disorder—Docetaxel—skin cancer	0.00062	0.00192	CcSEcCtD
Desvenlafaxine—Somnolence—Fluorouracil—skin cancer	0.000619	0.00191	CcSEcCtD
Desvenlafaxine—Malnutrition—Docetaxel—skin cancer	0.000616	0.0019	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Dactinomycin—skin cancer	0.000616	0.0019	CcSEcCtD
Desvenlafaxine—Decreased appetite—Fluorouracil—skin cancer	0.000606	0.00187	CcSEcCtD
Desvenlafaxine—Dysgeusia—Docetaxel—skin cancer	0.000603	0.00187	CcSEcCtD
Desvenlafaxine—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000601	0.00186	CcSEcCtD
Desvenlafaxine—Asthenia—Dactinomycin—skin cancer	0.0006	0.00185	CcSEcCtD
Desvenlafaxine—Diarrhoea—Dactinomycin—skin cancer	0.000572	0.00177	CcSEcCtD
Desvenlafaxine—Vomiting—Bleomycin—skin cancer	0.00057	0.00176	CcSEcCtD
Desvenlafaxine—Rash—Bleomycin—skin cancer	0.000565	0.00175	CcSEcCtD
Desvenlafaxine—Dermatitis—Bleomycin—skin cancer	0.000565	0.00175	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Temozolomide—skin cancer	0.000557	0.00172	CcSEcCtD
Desvenlafaxine—Syncope—Docetaxel—skin cancer	0.000553	0.00171	CcSEcCtD
Desvenlafaxine—Palpitations—Docetaxel—skin cancer	0.000544	0.00168	CcSEcCtD
Desvenlafaxine—Asthenia—Temozolomide—skin cancer	0.000543	0.00168	CcSEcCtD
Desvenlafaxine—Loss of consciousness—Docetaxel—skin cancer	0.000542	0.00167	CcSEcCtD
Desvenlafaxine—Convulsion—Docetaxel—skin cancer	0.000534	0.00165	CcSEcCtD
Desvenlafaxine—Nausea—Bleomycin—skin cancer	0.000532	0.00165	CcSEcCtD
Desvenlafaxine—Hypertension—Docetaxel—skin cancer	0.000532	0.00164	CcSEcCtD
Desvenlafaxine—Vomiting—Dactinomycin—skin cancer	0.000532	0.00164	CcSEcCtD
Desvenlafaxine—Rash—Dactinomycin—skin cancer	0.000527	0.00163	CcSEcCtD
Desvenlafaxine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	0.000521	0.00161	CcSEcCtD
Desvenlafaxine—Diarrhoea—Temozolomide—skin cancer	0.000517	0.0016	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Fluorouracil—skin cancer	0.000513	0.00159	CcSEcCtD
Desvenlafaxine—Dry mouth—Docetaxel—skin cancer	0.000513	0.00159	CcSEcCtD
Desvenlafaxine—Dizziness—Temozolomide—skin cancer	0.0005	0.00155	CcSEcCtD
Desvenlafaxine—Nausea—Dactinomycin—skin cancer	0.000497	0.00153	CcSEcCtD
Desvenlafaxine—Shock—Docetaxel—skin cancer	0.000495	0.00153	CcSEcCtD
Desvenlafaxine—Nervous system disorder—Docetaxel—skin cancer	0.000493	0.00152	CcSEcCtD
Desvenlafaxine—Tachycardia—Docetaxel—skin cancer	0.000491	0.00152	CcSEcCtD
Desvenlafaxine—Skin disorder—Docetaxel—skin cancer	0.000488	0.00151	CcSEcCtD
Desvenlafaxine—Vomiting—Temozolomide—skin cancer	0.000481	0.00149	CcSEcCtD
Desvenlafaxine—Rash—Temozolomide—skin cancer	0.000477	0.00147	CcSEcCtD
Desvenlafaxine—Diarrhoea—Fluorouracil—skin cancer	0.000477	0.00147	CcSEcCtD
Desvenlafaxine—Dermatitis—Temozolomide—skin cancer	0.000476	0.00147	CcSEcCtD
Desvenlafaxine—Headache—Temozolomide—skin cancer	0.000474	0.00146	CcSEcCtD
Desvenlafaxine—Dizziness—Fluorouracil—skin cancer	0.000461	0.00142	CcSEcCtD
Desvenlafaxine—Insomnia—Docetaxel—skin cancer	0.000455	0.00141	CcSEcCtD
Desvenlafaxine—Paraesthesia—Docetaxel—skin cancer	0.000452	0.0014	CcSEcCtD
Desvenlafaxine—Nausea—Temozolomide—skin cancer	0.000449	0.00139	CcSEcCtD
Desvenlafaxine—Somnolence—Docetaxel—skin cancer	0.000447	0.00138	CcSEcCtD
Desvenlafaxine—Vomiting—Fluorouracil—skin cancer	0.000443	0.00137	CcSEcCtD
Desvenlafaxine—Rash—Fluorouracil—skin cancer	0.000439	0.00136	CcSEcCtD
Desvenlafaxine—Dermatitis—Fluorouracil—skin cancer	0.000439	0.00136	CcSEcCtD
Desvenlafaxine—Decreased appetite—Docetaxel—skin cancer	0.000437	0.00135	CcSEcCtD
Desvenlafaxine—Headache—Fluorouracil—skin cancer	0.000436	0.00135	CcSEcCtD
Desvenlafaxine—Gastrointestinal disorder—Docetaxel—skin cancer	0.000434	0.00134	CcSEcCtD
Desvenlafaxine—Fatigue—Docetaxel—skin cancer	0.000434	0.00134	CcSEcCtD
Desvenlafaxine—Constipation—Docetaxel—skin cancer	0.00043	0.00133	CcSEcCtD
Desvenlafaxine—Nausea—Fluorouracil—skin cancer	0.000414	0.00128	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Docetaxel—skin cancer	0.00037	0.00115	CcSEcCtD
Desvenlafaxine—Asthenia—Docetaxel—skin cancer	0.000361	0.00112	CcSEcCtD
Desvenlafaxine—Diarrhoea—Docetaxel—skin cancer	0.000344	0.00106	CcSEcCtD
Desvenlafaxine—Dizziness—Docetaxel—skin cancer	0.000333	0.00103	CcSEcCtD
Desvenlafaxine—Vomiting—Docetaxel—skin cancer	0.00032	0.000988	CcSEcCtD
Desvenlafaxine—Rash—Docetaxel—skin cancer	0.000317	0.00098	CcSEcCtD
Desvenlafaxine—Dermatitis—Docetaxel—skin cancer	0.000317	0.000979	CcSEcCtD
Desvenlafaxine—Headache—Docetaxel—skin cancer	0.000315	0.000974	CcSEcCtD
Desvenlafaxine—Nausea—Docetaxel—skin cancer	0.000299	0.000923	CcSEcCtD
